CHARACTERISTICS AND OUTCOMES OF CHILDREN WITH HIGH-RISK HEPATOBLASTOMA AT THE VIETNAM NATIONAL CHILDREN’S HOSPITAL

Nguyen Thi Ngoc Lan1, Bui Ngoc Lan2, Tran Minh Dien1,2, Tran Minh Dien1,2
1 University of Medicine and Pharmacy, Vietnam National University
2 Vietnam National Children’s Hospital

##plugins.themes.vojs.article.main##

Abstract

Hepatoblastoma is a common malignant liver tumor in children, SIOPEL 3 high risk and SIOPEL 4 regimens improve treatment outcomes for children with high risk hepatoblastoma.


Objective: Describe the clinical and paraclinical features and initial treatment outcomes in children with high-risk hepatoblastoma.


Subjects and methods: 41 children under 15 years old were diagnosed with hepatoblastoma (2020-2024), treated according to high-risk regimen at the Oncology Center - Vietnam National Children’s Hospital. Method: case series, retrospective study.


Result: The median age was 12 months (min: 2 months old, max: 14 years old). Male/female ratio: 1.2/1. Common clinical symptoms were abdominal distension, palpable tumor, or incidental detection by abdominal ultrasound. About 90% of cases presented with anemia, 68.3% thrombocytosis. 51.2% had solitary tumors and 63.4% had right liver tumors. The rate of pulmonary metastasis was 31.7%. There were 4 cases of liver transplantation and 6 cases of embolization. The overall survival and event-free survival rates 3-year were 78,33% và 72,24%, respectively.


Conclusion: The treatment results of high-risk hepatoblastoma have improved signifcantly in recent years.

##plugins.themes.vojs.article.details##

References

1. Herzog CE, Andrassy RJ, Eftekhari F. Childhood cancers: hepatoblastoma. Oncologist 2000;5(6):445-53.https://doi.org/10.1634/theoncologist.5-6-445
2. Von Schweinitz D. Hepatoblastoma: recent developments in research and treatment. Semin Pediatr Surg 2012 Feb;21(1):21-30.https://doi.org/10.1053/j.sempedsurg.2011.10.011
3. Zsiros J, Brugieres L, Brock P et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL 4): a prospective, single-arm, feasibility study. Lancet Oncol 2013;14(9):834-42. https://doi.org/10.1016/s1470-2045(13)70272-9
4. Phùng, T. L., Lê, T. T. D. Kết quả điều trị u nguyên bào gan tại bệnh viện trung ương. Tạp Chí Y học lâm sàng Bệnh viện Trung ương Huế 2015;28:17-22
5. Đặng N.P, Nguyễn Đ.V, & Trần T. M. H. Đặc điểm bệnh u nguyên bào gan và kết quả điều trị ở trẻ em tại Bệnh viện Nhi đồng 2. Tạp Chí Y học lâm sàng Bệnh viện Trung Ương Huế 2020;59:75-79
6. Zsiros J, Maibach R, Shaford E et al. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: fnal results of the SIOPEL-3HR study. J Clin Oncol 2010;28(15):2584-2590. https://doi.org/10.1200/jco.2009.22.4857